AbbVie has entered into a $700 million licensing agreement with IGI Therapeutics to co-develop ISB 2001, a promising ...

A new report by the U.N. AIDS agency says the sudden withdrawal of U.S. funding has caused a “systemic shock” to the global effort against AIDS and HIV. Years of American-led investment into AIDS ...

US biopharma company AbbVie has inked a $700 million deal with IGI Therapeutics to develop and sell ISB 2001, an experimental drug for blood cancer.

Thousands of customers are set to receive payments after purchasing a weight loss supplement once described as the “Gastric ...

Other research, including a review of over 80 studies, found that AI chatbots are especially helpful for improving mood, reducing stress and even helping people sleep better. In one study, a chatbot ...

The global baby milk market is poised for substantial expansion, projected to grow from USD 17.2 billion in 2025 to USD 29.6 ...